| IPAD-DB ID | S01274 | 
| Name | Umibecestat | 
| Category | Synthetic compounds | 
| 2D Structure | 
                         | 
                
| 3D Structure | |
| Molecular Formula | C 1 9 H 1 5 C l F 7 N 5 O 2 | 
| Molecular Weight | 513.8 g/mol | 
| IUPAC Name | N-[6-[(3R, 6R)-5-amino-3, 6-dimethyl-6-(trifluoromethyl)-2H-1, 4-oxazin-3-yl]-5-fluoropyridin-2-yl]-3-chloro-5-(trifluoromethyl)pyridine-2-carboxamide | 
| InChI | InChI=1S/C19H15ClF7N5O2/c1-16(7-34-17(2, 15(28)32-16)19(25, 26)27)13-10(21)3-4-11(30-13)31-14(33)12-9(20)5-8(6-29-12)18(22, 23)24/h3-6H, 7H2, 1-2H3, (H2, 28, 32)(H, 30, 31, 33)/t16-, 17+/m0/s1 | 
| InChIKey | PSBBWFNMHDUTRH-DLBZAZTESA-N | 
| Canonical SMILES | CC1(COC(C(=N1)N)(C)C(F)(F)F)C2=C(C=CC(=N2)NC(=O)C3=C(C=C(C=N3)C(F)(F)F)Cl)F | 
| PubChem CID | 88602735 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | - | 
| Molecular Weight(Computed by SwissADME) | 513.8 | 
| Hac(Computed by SwissADME) | 34 | 
| Volume(Computed by ADMETlab 2.0) | 420.667 | 
| Density(Computed by ADMETlab 2.0) | 1.22 | 
| nRing(Computed by ADMETlab 2.0) | 3 | 
| MaxRing(Computed by ADMETlab 2.0) | 6 | 
| nHet(Computed by ADMETlab 2.0) | 15 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 21 | 
| Flexibility(Computed by ADMETlab 2.0) | 0.238 | 
| Stero Centers(Computed by ADMETlab 2.0) | 2 | 
| LogS(Computed by ADMETlab 2.0) | -3.518 | 
| LogD(Computed by ADMETlab 2.0) | 3.588 | 
| logP(Computed by ADMETlab 2.0) | 3.457 | 
| TPSA(Computed by SwissADME) | 102.49 | 
| Hbond Acceptor(Computed by SwissADME) | 12 | 
| Hbond Donor(Computed by SwissADME) | 2 | 
| Rotatable Bonds(Computed by SwissADME) | 6 | 
| GI Absorption(Computed by SwissADME) | Low | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No | 
| P-gp Substrate(Computed by SwissADME) | Yes | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | Yes | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | Yes | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -7.35 | 
| Lipinski(Computed by SwissADME) | 1 | 
| Ghose(Computed by SwissADME) | 2 | 
| Veber(Computed by SwissADME) | 0 | 
| Egan(Computed by SwissADME) | 1 | 
| Muegge(Computed by SwissADME) | 1 | 
| Bioavailability Score(Computed by SwissADME) | 0.55 |